A publicly held medical company that recently moved its headquarters to Denver wants to speed up its acquisition of a New Jersey company.
BioScrip Inc., (Nasdaq: BIOS) which provides home infusion services, said it wants to expedite its acquisition of HS Infusion Holdings, Inc., in an $85 million deal ($80 million cash; $5 million stock) that was announced in June.
The current deal is now valued at $67.5 million in cash, plus stock. To speed up completion of the deal, the two companies agreed not to seek stockholder approval for parts of the deal.
Instead, stockholder approval will be sought after the deal closes.
(© 2016 American City Business Journals.